These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 5059372

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effects of tremorine and oxotremorine in hyperthyroid mice.
    Waite R, Spencer PS.
    J Pharm Pharmacol; 1968 Mar; 20(3):199-203. PubMed ID: 4385048
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of L-5HTP on tremorine- or oxotremorine-induced tremor in mice and rats.
    Omori K, Kojima T.
    Jpn J Pharmacol; 1973 Dec; 23(6):901-3. PubMed ID: 4274100
    [No Abstract] [Full Text] [Related]

  • 8. Effects of some beta adrenergic blocking agents on tremorine induced tremor, hypothermia and cholinergic effects in rats.
    Singh KP, Bhandari DS, Mahawar MM.
    Indian J Med Res; 1973 Oct; 61(10):1544-9. PubMed ID: 4149980
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antagonism by naloxone of anti-tremorine effect of bromocriptine in mice.
    Shukla VK, Garg SK, Kulkarni SK.
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):303-6. PubMed ID: 3613759
    [Abstract] [Full Text] [Related]

  • 11. Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF).
    Plotnikoff NP, Kastin AJ, Anderson MS, Schally AV.
    Proc Soc Exp Biol Med; 1972 Jul; 140(3):811-4. PubMed ID: 5064701
    [No Abstract] [Full Text] [Related]

  • 12. Central and peripheral actions of the acetylcholine antagonist, ambutonium bromide.
    Southgate PJ.
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):376-82. PubMed ID: 4401084
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of desmethylimipramine and other "anti-tremorine" drugs on the metabolism of tremorine and oxotremorine in rats and mice.
    Sjöqvist F, Hammer W, Schumacher H, Gillette J.
    Biochem Pharmacol; 1968 Jun; 17(6):915-34. PubMed ID: 5661354
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of tremorine, physostigmine and tremor blocking drugs on brain monoamines.
    Rogers KJ, Slater P.
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):68-72. PubMed ID: 5111328
    [No Abstract] [Full Text] [Related]

  • 19. Different central effects of the 5-HT antagonists mianserine and cyproheptadine.
    van Riezen H.
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):256-69. PubMed ID: 5054734
    [No Abstract] [Full Text] [Related]

  • 20. Tremorine-oxotremorine-induced tremor, hypothermia and analgesia, and physostigmine toxicity, in mice after pretreatment with beta-adrenoceptor antagonists.
    Barar FS, Madan BR.
    J Pharm Pharmacol; 1976 Apr; 28(4):286-9. PubMed ID: 6716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.